Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Ringelstein

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Neurology|November 23, 2018
High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2025
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B CellsSarah Dybowski, Jacqueline Thode, Marie Freier, et al.
JAMA Neurology|April 20, 2013
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responsesBernd C Kieseier, Olaf Stüve, Thomas Dehmel, et al.
Clinical Neuroradiology|March 16, 2022
Contrast Neurotoxicity and its Association with Symptomatic Intracranial Hemorrhage After Mechanical ThrombectomyEdgar R Lopez-Navarro, Christofer Delfs, Andrea Jarre, et al.
European Journal of Neurology|June 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United KingdomDaniel Engels, Chiara Rocchi, Mirasol Forcadela, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Visual evoked potentials in neuromyelitis optica and its spectrum disordersMarius Ringelstein, Ingo Kleiter, Ilya Ayzenberg, et al.
BMC Medical Imaging|January 3, 2024
Central intra-lesional iron deposits as a possible novel imaging marker at 7 Tesla MRI in Susac Syndrome - an exploratory studyDaniel Strunk, Tim Sinnecker, Ilka Kleffner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosisImke Metz, Tim Beißbarth, David Ellenberger, et al.
Annals of Clinical and Translational Neurology|January 16, 2015
Subtle retinal pathology in amyotrophic lateral sclerosisMarius Ringelstein, Philipp Albrecht, Martin Südmeyer, et al.
Plos One|April 20, 2012
Optical coherence tomography in parkinsonian syndromesPhilipp Albrecht, Ann-Kristin Müller, Martin Südmeyer, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Neurology|November 23, 2018
High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2025
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B CellsSarah Dybowski, Jacqueline Thode, Marie Freier, et al.
JAMA Neurology|April 20, 2013
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responsesBernd C Kieseier, Olaf Stüve, Thomas Dehmel, et al.
Clinical Neuroradiology|March 16, 2022
Contrast Neurotoxicity and its Association with Symptomatic Intracranial Hemorrhage After Mechanical ThrombectomyEdgar R Lopez-Navarro, Christofer Delfs, Andrea Jarre, et al.
European Journal of Neurology|June 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United KingdomDaniel Engels, Chiara Rocchi, Mirasol Forcadela, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Visual evoked potentials in neuromyelitis optica and its spectrum disordersMarius Ringelstein, Ingo Kleiter, Ilya Ayzenberg, et al.
BMC Medical Imaging|January 3, 2024
Central intra-lesional iron deposits as a possible novel imaging marker at 7 Tesla MRI in Susac Syndrome - an exploratory studyDaniel Strunk, Tim Sinnecker, Ilka Kleffner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosisImke Metz, Tim Beißbarth, David Ellenberger, et al.
Annals of Clinical and Translational Neurology|January 16, 2015
Subtle retinal pathology in amyotrophic lateral sclerosisMarius Ringelstein, Philipp Albrecht, Martin Südmeyer, et al.
Plos One|April 20, 2012
Optical coherence tomography in parkinsonian syndromesPhilipp Albrecht, Ann-Kristin Müller, Martin Südmeyer, et al.
Pageof 12